Whitehawk Therapeutics, Inc. Common Stock WHWK Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -68.5%-86.2pp | -21.8%+59.0pp | -13.8%+52.1pp | -8.3%— | 17.7%— | |
| Efficiency | ||||||
| Asset turnover | 0×— | 0.1×— | 0.1×— | —— | —— | |
| Liquidity | ||||||
| Current ratio | 11.4×-7.6× | 10.3×+6.7× | 16.8×+11.9× | 20.4×— | 19×— | |
| Per Share | ||||||
| Book value per share | $1.68-69.8% | $2.20+13.4% | $2.27-10.8% | $2.49-14.6% | $5.55+65.6% | |
| Valuation | ||||||
| Market capitalization | $226.49M+131% | —— | —— | —— | —— | |
| Price / book | 1.8×+1.3× | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Whitehawk Therapeutics, Inc. Common Stock's profit margins?
- Whitehawk Therapeutics, Inc. Common Stock (WHWK) runs a 89.4% gross margin and a -1601.1% operating margin, with a -288.3% net margin.
- Where do Whitehawk Therapeutics, Inc. Common Stock's ratios come from?
- Every ratio is computed from Whitehawk Therapeutics, Inc. Common Stock's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.